日本における創傷管理処置市場

◆英語タイトル:Japan Wound Care Management Procedures Outlook to 2020
◆発行会社/調査会社:GlobalData
◆商品コード:GDMEMC0056PDB
◆発行日:2014年10月1日
◆調査対象地域:日本
◆産業分野:医療機器・装置
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,500 ⇒換算¥169,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD4,500 ⇒換算¥508,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の市場調査資料のご購入、委託調査サービスに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[日本における創傷管理処置市場]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Japan Wound Care Management Procedures Outlook to 2020

Summary

GlobalData’s new report, “Japan Wound Care Management Procedures Outlook to 2020″, provides key procedures data on the Japan Wound Care Management Procedures. The report provides procedure volumes within market categories – Tissue Engineered – Skin Substitute Procedures (Synthetic Skin Substitute Procedures, Biosynthetic Skin Substitute Procedures and Biologic Skin Substitute Procedures ((Allograft Cellular and Acellular Procedures) and Xenograft Acellular Procedures), Wound Debridement Procedures and Ostomy Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- Procedure volumes data for Wound Care Management Procedures segments – Tissue Engineered – Skin Substitute Procedures (Synthetic Skin Substitute Procedures, Biosynthetic Skin Substitute Procedures and Biologic Skin Substitute Procedures ((Allograft Cellular and Acellular Procedures) and Xenograft Acellular Procedures), Wound Debridement Procedures and Ostomy Procedures.
- Projections for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

*** レポート目次(コンテンツ)***

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Wound Care Management Procedures Segmentation 4
2.3 Definitions of Procedures Covered in the Report 4
3 Wound Care Management, Japan 6
3.1 Wound Care Management, Japan, 2005-2020 6
3.2 Wound Care Management, Japan Category Comparison by Procedures, 2005-2020 8
3.3 Wound Care Management, Japan, 2005-2013 9
3.4 Wound Care Management, Japan, 2013-2020 11
4 Ostomy Procedures, Japan 13
4.1 Ostomy Procedures, Japan, 2005-2013 13
4.2 Ostomy Procedures, Japan, 2013-2020 15
5 Tissue Engineered – Skin Substitute Procedures, Japan 17
5.1 Tissue Engineered – Skin Substitute Procedures, Japan, 2005-2013 17
5.2 Tissue Engineered – Skin Substitute Procedures, Japan, 2013-2020 19
5.2.1 Biologic Skin Substitute Procedures, Japan, 2005-2013 21
5.2.1.1 Allograft Procedures, Japan, 2005-2013 23
5.2.2 Biologic Skin Substitute Procedures, Japan, 2013-2020 25
5.2.2.1 Allograft Procedures, Japan, 2013-2020 27
6 Wound Debridement Procedures, Japan 29
6.1 Wound Debridement Procedures, Japan, 2005-2013 29
6.2 Wound Debridement Procedures, Japan, 2013-2020 31
7 Appendix 32
7.1 Research Methodology 33
7.1.1 Coverage 33
7.1.2 Secondary Research 33
7.1.3 Primary Research 34
7.1.4 Market Modeling and Forecasting 35
7.1.5 Company Share Analysis 38
7.1.6 Distribution Share Analysis 39
7.2 Expert Panel 39
7.3 GlobalData Consulting 40
7.4 Contact Us 40
7.5 Disclaimer 40

1.1 List of Tables
Table 1: Wound Care Management, Japan, 2005-2020 7
Table 2: Wound Care Management, Japan Category Comparison by Procedures, 2005-2020 8
Table 3: Wound Care Management, Japan, Historic, 2005-2013 10
Table 4: Wound Care Management, Japan, Forecast, 2013-2020 12
Table 5: Ostomy Procedures, Japan, Historic, 2005-2013 14
Table 6: Ostomy Procedures, Japan, Forecast, 2013-2020 16
Table 7: Tissue Engineered - Skin Substitute Procedures, Japan, Historic, 2005-2013 18
Table 8: Tissue Engineered - Skin Substitute Procedures, Japan, Forecast, 2013-2020 20
Table 9: Biologic Skin Substitute Procedures, Japan, Historic, 2005-2013 22
Table 10: Allograft Procedures, Japan, Historic, 2005-2013 24
Table 11: Biologic Skin Substitute Procedures, Japan, Forecast, 2013-2020 26
Table 12: Allograft Procedures, Japan, Forecast, 2013-2020 28
Table 13: Wound Debridement Procedures, Japan, Historic, 2005-2013 30
Table 14: Wound Debridement Procedures, Japan, Forecast, 2013-2020 31
Table 15: Total Number of Primary Research Participants, Wound Care Management, by Country 35

1.2 List of Figures
Figure 1: Wound Care Management, Japan, 2005-2020 6
Figure 2: Wound Care Management, Japan Category Comparison by Procedures, 2005-2020 8
Figure 3: Wound Care Management, Japan, Historic, 2005-2013 9
Figure 4: Wound Care Management, Japan, Forecast, 2013-2020 11
Figure 5: Ostomy Procedures, Japan, Historic, 2005-2013 13
Figure 6: Ostomy Procedures, Japan, Forecast, 2013-2020 15
Figure 7: Tissue Engineered - Skin Substitute Procedures, Japan, Historic, 2005-2013 17
Figure 8: Tissue Engineered - Skin Substitute Procedures, Japan, Forecast, 2013-2020 19
Figure 9: Biologic Skin Substitute Procedures, Japan, Historic, 2005-2013 21
Figure 10: Allograft Procedures, Japan, Historic, 2005-2013 23
Figure 11: Biologic Skin Substitute Procedures, Japan, Forecast, 2013-2020 25
Figure 12: Allograft Procedures, Japan, Forecast, 2013-2020 27
Figure 13: Wound Debridement Procedures, Japan, Historic, 2005-2013 29
Figure 14: Wound Debridement Procedures, Japan, Forecast, 2013-2020 31
Figure 15: GlobalData Epidemiology-Based Forecasting Model 37
Figure 16: GlobalData Capital Equipment-Based Forecasting Model 38
Figure 17: Primary Interviews by Participant Type (%) 39

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDMEMC0056PDB )"日本における創傷管理処置市場" (英文:Japan Wound Care Management Procedures Outlook to 2020)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。